BioSight Ltd, a pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders, strengthens its Board of Directors with the appointment of Dr. Gary Gordon, an industry executive and a member of Israel Biotech Fund Venture Advisory Team.
Biosight Strengthens Board of Directors with Appointment of Industry Executive, Gary Gordon, M.D, Ph.D.
